Cargando…

The airway microbiota of non‐small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation

BACKGROUND: Accumulating studies have suggested the airway microbiota in lung cancer patients is significantly different from that of healthy controls. However, little is known about the relationship between airway microbiota and important clinical parameters of lung cancer. In this study, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Dan Hui, He, Jing, Su, Xiao Fang, Wen, Ya Na, Zhang, Shu Jia, Liu, Lai Yu, Zhao, Haijin, Ye, Cui Pin, Wu, Jian Hua, Cai, Shaoxi, Dong, Hangming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930493/ https://www.ncbi.nlm.nih.gov/pubmed/35142041 http://dx.doi.org/10.1111/1759-7714.14340

Ejemplares similares

High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway
por: HUANG, WUFENG, et al.
Publicado: (2016)

The role of secreted Hsp90α in HDM-induced asthmatic airway epithelial barrier dysfunction
por: Ye, Cuiping, et al.
Publicado: (2019)

RAGE mediates airway inflammation via the HDAC1 pathway in a toluene diisocyanate-induced murine asthma model
por: Peng, Xianru, et al.
Publicado: (2022)

Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma
por: Huang, DanHui, et al.
Publicado: (2023)

Distinct roles of short and long thymic stromal lymphopoietin isoforms in house dust mite-induced asthmatic airway epithelial barrier disruption
por: Dong, Hangming, et al.
Publicado: (2016)

Newly diagnosed asthma in China: initial severity and changes over a 1-year management period
por: Hu, Zhizhen, et al.
Publicado: (2022)

Clinical implications of the concentration of alveolar nitric oxide in non-small cell lung cancer
por: Chang, Xiaodan, et al.
Publicado: (2023)

GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells
por: Wan, Xuan, et al.
Publicado: (2023)

The AKT inhibitor MK2206 suppresses airway inflammation and the pro-remodeling pathway in a TDI-induced asthma mouse model
por: Cui, Haiyan, et al.
Publicado: (2020)

Short isoform thymic stromal lymphopoietin reduces inflammation and aerobic glycolysis of asthmatic airway epithelium by antagonizing long isoform thymic stromal lymphopoietin
por: Yu, Changhui, et al.
Publicado: (2022)

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer
por: Liao, Hua, et al.
Publicado: (2023)

Store-Operated Ca(2+) Entry Plays a Role in HMGB1-Induced Vascular Endothelial Cell Hyperpermeability
por: Zou, Mengchen, et al.
Publicado: (2015)

Establishment and Evaluation of a Simplified Evaluation System of Acute Respiratory Distress Syndrome
por: Lu, Shubiao, et al.
Publicado: (2013)

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
por: Simonetti, Sara, et al.
Publicado: (2010)

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers
por: Vaclova, Tereza, et al.
Publicado: (2021)

Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)
por: Shen, Yongchun, et al.
Publicado: (2018)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
por: Cho, Jaeyoung, et al.
Publicado: (2016)

A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
por: Cui, Ran, et al.
Publicado: (2022)

First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study
por: Wu, Yahua, et al.
Publicado: (2023)

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations
por: Jiang, Yu, et al.
Publicado: (2023)

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
por: Van Assche, Katrijn, et al.
Publicado: (2014)

Effect and mechanism of calpains on pediatric lobar pneumonia
por: Yin, Genquan, et al.
Publicado: (2016)

Tetrandrine Modulates Rheb-mTOR Signaling-Mediated Selective Autophagy and Protects Pulmonary Fibrosis
por: Liu, Yuanyuan, et al.
Publicado: (2021)

Tumor PKCδ instigates immune exclusion in EGFR-mutated non–small cell lung cancer
por: Zuo, Yi-Han, et al.
Publicado: (2022)

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
por: Fang, Shu, et al.
Publicado: (2014)

Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations
por: Zheng, LinPeng, et al.
Publicado: (2019)

Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation
por: Chen, Yu-Mu, et al.
Publicado: (2021)

Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes
por: Zhang, Qingling, et al.
Publicado: (2016)

Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma
por: Nie, Yunqiang, et al.
Publicado: (2017)

EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?
por: Liu, Bailong, et al.
Publicado: (2021)

LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab
por: Wu, Yahua, et al.
Publicado: (2023)

Apigenin Combined With Gefitinib Blocks Autophagy Flux and Induces Apoptotic Cell Death Through Inhibition of HIF-1α, c-Myc, p-EGFR, and Glucose Metabolism in EGFR L858R+T790M-Mutated H1975 Cells
por: Chen, ZiSheng, et al.
Publicado: (2019)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
por: Chung, Fu-Tsai, et al.
Publicado: (2015)

Association between EGFR mutation and expression of BRCA1 and RAP80 in non-small cell lung cancer
por: Sun, Xia, et al.
Publicado: (2018)

First-Line EGFR-TKIs Treatment in Stage I Non-Small-Cell Lung Cancer Patients Harboring EGFR Gene Mutations with Postoperative Intrapulmonary Recurrence
por: Zhu, Zhouyu, et al.
Publicado: (2021)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

A Systemic Inflammatory Endotype of Asthma With More Severe Disease Identified by Unbiased Clustering of the Serum Cytokine Profile
por: Liang, Zhenyu, et al.
Publicado: (2016)

Abnormal neutrophil polarization in chronic obstructive pulmonary disease and how cigarette smoke extracts attract neutrophils
por: Deng, Fan, et al.
Publicado: (2022)

Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
por: Chen, Dan, et al.
Publicado: (2016)

Radiotherapy with continued EGFR‐TKIs for oligoprogressive disease in EGFR‐mutated non‐small cell lung cancer: A real‐world study
por: Hu, Chunhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_945i0nml6nd40ag0gjt7cu69bl